Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term efficacy and safety of ramelteon in adults with chronic insomnia
2004-004351-20Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Insomnia comparing Ramelteon with Placebo (2 arms). Primary endpoint: Latency to persistent sleep (LPS). Started Oct 2005; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2004-004351-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004351-20.